Monday, December 17, 2018

New Evidence On Medicare Health Plans Urges Change In Payment Policy

DECEMBER 11, 2018 10.1377/hblog20181207.837174
Medicare offers health coverage to the elderly through two types of plans: traditional Medicare, which pays providers a fee for each service they perform, and Medicare Advantage (MA) plans, in which Medicare makes predetermined monthly payments to private plans for each beneficiary they enroll, independent of the volume of services used by each beneficiary. Today, one-third of all Medicare beneficiaries are enrolled in MA plans.
Ambiguous Early Evidence On Medicare Advantage
The role of MA plans in the Medicare program has always been controversial, in part because early estimates of MA plans’ effects on cost and quality of care were ambiguous. Analyses of cost differencesperformed in the 1980s and 1990s found that MA enrollees cost the program more than they would have had they been enrolled in fee-for-service Medicare (MA enrollees were healthier than fee-for-service enrollees according to criteria not included in the risk adjustment methods used at the time). More sophisticated risk adjustment methods have reduced the effects of “favorable selection” into MA plans. Early cost comparison efforts faced another critical limitation: the absence of individual claims for beneficiary use in MA. Because MA plans were not required to provide this data, early studies were usually based on indirect comparisons of service use in MA plans versus fee-for-service Medicare.
New Evidence On Cost And Quality
A forthcoming study by Vilsa Curto and colleagues uses detailed claims data for 2010 covering a large share of the MA market and shows that health care spending per enrollee per month in MA is 9 percent to 30 percent lower than in fee-for-service Medicare. The study further shows that this difference in spending vis-à-vis fee-for-service Medicare is due primarily to lower use of services in MA plans, not lower prices paid to providers for services.
Reduced spending on health care services does not necessarily result in lower quality of care. Joseph P. Newhouse and Thomas G. McGuire reviewthe literature on quality of care comparisons and conclude that, “because comparisons of MA’s and [fee-for-service Medicare’s] quality are still severely limited, we cannot make an overall assessment with confidence, but most of the few comparisons do favor MA. In other words, the integration and coordination of care that MA fosters may well pay off in higher-quality care.”
We now have evidence that MA plans offer health care services of comparable or better quality than fee-for-service Medicare, while spending 9 percent to 30 percent less. There are three reasons to care about these results. First, wasteful spending on government-sponsored health care programs creates an unnecessary financial burden for beneficiaries and other taxpayers. Second, it robs other government programs of needed revenue. Third, unnecessary encounters with the health care system can place beneficiaries in harm’s way.
Implications Of New Evidence For Medicare Payment Policy
In light of new studies affirming the benefits of MA, how can the payment system be improved? Currently, MA plans submit bids to cover the cost of care for their enrollees. Those bids are compared to a government-determined benchmark, which reflects the cost of caring for similar beneficiaries in fee-for-service Medicare. If an MA plan’s bid is below the benchmark, the plan receives part of the difference to fund additional benefits and lower cost sharing. Most MA plan bids are below the applicable benchmarks, and those plans receive a competitive advantage from the extra benefits that result. However, as noted by Austin Frakt, “the benchmark has nothing to do with plan costs.” Curto and colleagues found that using fee-for-service Medicare costs as the benchmark for MA payments resulted in $21 billion of overpayments in 2010.
Overpayment of MA plans could be eliminated by basing government payments on bids submitted by both fee-for-service Medicare and MA plans to cover the cost of Medicare’s entitlement benefits. Medicare beneficiaries would be guaranteed access to at least one health plan in their county for no more than the Part B premium, but if they chose a more expensive health plan, they would pay the extra cost out of pocket.
We reviewed 12 examples of Medicare’s attempts to use competitive bidding to price its payment for particular health services. We concluded that: “All of the competitive-pricing demonstrations that reached the point of bid evaluation—even those using bidding models that were watered down under provider pressure, as many were—demonstrated that they would save substantial amounts of money.” Moreover, competitive bidding in various forms has been used successfully for major Medicare benefits, including durable medical equipment and Part D prescription drugs.
The Medicare Payment Advisory Commission (MedPAC) has urged that government payments for the Medicare entitlement benefit reflect a “policy of financial neutrality” for the MA program that exerts “consistent financial pressure on both the [fee-for service Medicare] and MA programs.” In addition, MedPAC has expressed concern that, in some market areas, the MA share of the market has grown large enough that the remaining beneficiaries in fee-for-service Medicare do not provide a reliable basis for the benchmark. The obvious way to address both points is to introduce competitive pricing with fee-for-service Medicare as one of the bidding health plans in each market area and to use its bid, along with MA bids, to set the benchmark. Fee-for-service Medicare’s price would be compared to the prices of MA alternatives, giving beneficiaries a price signal they now lack in choosing between the two types of plans. In a competitive bidding system, if fee-for-service Medicare were more expensive in a given area, beneficiaries would have to pay an additional premium for the extra cost.
Easing Objections To Competitive Pricing
The main objection to competitive bidding systems is political. MA plans are accustomed to competing through marketing and services. Competitive bidding based on the entitlement benefit package forces all health plans to compete on price. MA plans and many beneficiary advocates have resisted competitive bidding on price since the inception of the program, and that has translated into serious political resistance to competitive bidding.
Opponents of competitive pricing rightly point out that charging “extra” (above the Part B premium) for fee-for-service Medicare would require a change in the entitlement legislation. However, the recent evidence on cost and quality of MA versus fee-for-service Medicare, coupled with the pressure that entitlement programs put on the federal budget, suggests that the time has come to seriously consider such a change. Why spend so much on Medicare entitlement benefits when an equally good alternative is available for less?
Moving to a full competitive bidding system should respect the reasonable expectations of beneficiaries about their out-of-pocket costs and terms of coverage in the short run. There are several ways to ease the transition to a more efficient system. First, the new system could be introduced over a number of years. The new benchmark could be a mix of fee-for-service Medicare costs and the bids, gradually increasing the contribution of the bids over time and allowing beneficiaries to adjust. Second, the savings from competitive bidding could be used to enhance what beneficiaries are receiving: for example, to improve the entitlement benefits or to reduce the Part B premium.
Conclusion
We have no illusion that these enhancements will make the opposition to competitive bidding for the entitlement benefit disappear. However, recent evidence underscores the need to work toward a better system that encourages all health plans to compete on both price and quality of care, to move benchmarks closer to the true costs of care for fee-for-service Medicare and MA, and to bring the incentives for beneficiary choice between fee-for-service Medicare and MA into better alignment with the cost of those different options.
https://www.healthaffairs.org/do/10.1377/hblog20181207.837174/full/

No comments:

Post a Comment